| Zacks Company Profile for Nascent Pharma Holdings, Inc. (NASC : OTC) |
|
|
| |
| • Company Description |
| Nascent Pharma Holdings Inc. is a forward-thinking pharmaceutical Intellectual Property company, focused on maximizing the value of its cannabis patent portfolios. Nascent Pharma Holdings Inc., formerly known as Can B Corp., is based in HICKSVILLE, NY.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.02 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 77,681 shares |
| Shares Outstanding: 90.22 (millions) |
| Market Capitalization: $1.58 (millions) |
| Beta: 0.53 |
| 52 Week High: $0.18 |
| 52 Week Low: $0.01 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-10.26% |
-12.61% |
| 12 Week |
-15.05% |
-18.57% |
| Year To Date |
-50.98% |
-57.15% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
960 South Broadway Suite 120
-
Hicksville,NY 11801
USA |
ph: 516-595-9544
fax: - |
None |
http://www.canbcorp.com |
|
|
| |
| • General Corporate Information |
Officers
Marco Alfonsi - Chief Executive Officer and Chairman
Stanley L. Teeple - Chief Financial Officer
Frederick Alger Boyer - Director
James Murphy - Director
Ronald A. Silver - Director
|
|
Peer Information
Nascent Pharma Holdings, Inc. (GSAC)
Nascent Pharma Holdings, Inc. (CASI)
Nascent Pharma Holdings, Inc. (ALCD.)
Nascent Pharma Holdings, Inc. (OMNN)
Nascent Pharma Holdings, Inc. (CGPI.)
Nascent Pharma Holdings, Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 63108T105
SIC: 5122
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 11/18/25
|
|
Share - Related Items
Shares Outstanding: 90.22
Most Recent Split Date: (:1)
Beta: 0.53
Market Capitalization: $1.58 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/18/25 |
|
|
|
| |
